These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 33912154)
1. Allogeneic Hematopoietic Stem Cell Transplantation Mobilized With Pegylated Granulocyte Colony-Stimulating Factor Ameliorates Severe Acute Graft-Versus-Host Disease Through Enrichment of Monocytic Myeloid-Derived Suppressor Cells in the Graft: A Real World Experience. Li L; Yin J; Li Y; Wang C; Mao X; Wei J; Cao Y; Wang N; Lin L; Xu J; Zhang Y Front Immunol; 2021; 12():621935. PubMed ID: 33912154 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors. Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563 [TBL] [Abstract][Full Text] [Related]
4. The transplantation effect of pegylated granulocyte colony-stimulating factor mobilized hematopoietic stem cells may be superior to that of G-CSF mobilized hematopoietic stem cells in haploidentical allogeneic hematopoietic cell transplantation. Cao J; Zhuang X; Pei R; Lu Y; Ye P; Chen D; Du X; Li S; Liu X Curr Res Transl Med; 2024 Dec; 72(4):103473. PubMed ID: 39326334 [TBL] [Abstract][Full Text] [Related]
5. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia. Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF. Hill GR; Morris ES; Fuery M; Hutchins C; Butler J; Grigg A; Roberts A; Bradstock K; Szer J; Kennedy G; Morton J; Durrant S Biol Blood Marrow Transplant; 2006 Jun; 12(6):603-7. PubMed ID: 16737933 [TBL] [Abstract][Full Text] [Related]
7. Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation. Lv M; Zhao XS; Hu Y; Chang YJ; Zhao XY; Kong Y; Zhang XH; Xu LP; Liu KY; Huang XJ Am J Hematol; 2015 Jan; 90(1):E9-E16. PubMed ID: 25303038 [TBL] [Abstract][Full Text] [Related]
8. Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor. Teipel R; Oelschlägel U; Wetzko K; Schmiedgen M; Kramer M; Rücker-Braun E; Hölig K; von Bonin M; Heidrich K; Fuchs A; Ordemann R; Kroschinsky F; Bornhäuser M; Hütter G; Schmidt H; Ehninger G; Schetelig J; Heidenreich F Biol Blood Marrow Transplant; 2018 Nov; 24(11):2171-2177. PubMed ID: 29935214 [TBL] [Abstract][Full Text] [Related]
9. Early myeloid-derived suppressor cells (HLA-DR Wang K; Lv M; Chang YJ; Zhao XY; Zhao XS; Zhang YY; Sun YQ; Wang ZD; Suo P; Zhou Y; Liu D; Zhai SZ; Hong Y; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ J Hematol Oncol; 2019 Mar; 12(1):31. PubMed ID: 30885244 [TBL] [Abstract][Full Text] [Related]
10. Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation. Gattillo S; Marktel S; Rizzo L; Malato S; Malabarba L; Coppola M; Assanelli A; Milani R; De Freitas T; Corti C; Bellio L; Ciceri F Transfusion; 2015 Aug; 55(8):1993-2000. PubMed ID: 25721167 [TBL] [Abstract][Full Text] [Related]
11. Impact of Single-Dose Plerixafor as an Adjunct to Granulocyte Colony-Stimulating Factor-Based Peripheral Blood Stem Cell Mobilization on the Graft Composition and Outcome for T Cell-Replete Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Comparative Study. Jaiswal SR; Bhakuni P; Joy A; Murli N; Bharadwaj P; Zaman S; Nedunchezian M; Chakrabarti S Biol Blood Marrow Transplant; 2018 Mar; 24(3):542-548. PubMed ID: 29191663 [TBL] [Abstract][Full Text] [Related]
13. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Dreger P; Haferlach T; Eckstein V; Jacobs S; Suttorp M; Löffler H; Müller-Ruchholtz W; Schmitz N Br J Haematol; 1994 Jul; 87(3):609-13. PubMed ID: 7527648 [TBL] [Abstract][Full Text] [Related]
14. Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets. Melve GK; Ersvaer E; Eide GE; Kristoffersen EK; Bruserud Ø Front Immunol; 2018; 9():845. PubMed ID: 29770133 [TBL] [Abstract][Full Text] [Related]
15. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor. Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278 [TBL] [Abstract][Full Text] [Related]
16. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation. MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491 [TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Pan L; Teshima T; Hill GR; Bungard D; Brinson YS; Reddy VS; Cooke KR; Ferrara JL Blood; 1999 Jun; 93(12):4071-8. PubMed ID: 10361103 [TBL] [Abstract][Full Text] [Related]
18. Regulatory γδ T cells induced by G-CSF participate in acute graft-versus-host disease regulation in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation. Xuan L; Wu X; Qiu D; Gao L; Liu H; Fan Z; Huang F; Jin Z; Sun J; Li Y; Liu Q J Transl Med; 2018 May; 16(1):144. PubMed ID: 29801459 [TBL] [Abstract][Full Text] [Related]
19. Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease. Xuan L; Wu X; Zhang Y; Fan Z; Ling Y; Huang F; Zhang F; Zhai X; Liu Q J Transl Med; 2011 Dec; 9():215. PubMed ID: 22171570 [TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes and graft characteristics in pediatric hematopoietic stem cell transplantation: Effect of granulocyte-colony stimulating factor priming. Fettah A; Özbek N; Azık F; Tavil B; Özgüner M; Avcı Z; Işık P; Yaralı N; Uçkan D; Tunç B Transfus Apher Sci; 2015 Jun; 52(3):332-8. PubMed ID: 25779226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]